ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC

BackgroundImmunotherapy has been proven effective among several human cancer types, including Squamous cell lung carcinoma (SqCLC). ERAP2 plays a pivotal role in peptide trimming of many immunological processes. However, the prognostic role of ERAP2 and its relationship with immune cell infiltration...

Full description

Bibliographic Details
Main Authors: Zhenlin Yang, He Tian, Fenglong Bie, Jiachen Xu, Zheng Zhou, Junhui Yang, Renda Li, Yue Peng, Guangyu Bai, Yanhua Tian, Ying Chen, Lei Liu, Tao Fan, Chu Xiao, Yujia Zheng, Bo Zheng, Jie Wang, Chunxiang Li, Shugeng Gao, Jie He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Immunology
Subjects:
ERAP2
squamous cell lung cancer (SqCLC)
prognosis
immune microenvironment
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.788985/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.788985/full

Similar Items